133 related articles for article (PubMed ID: 35189493)
21. Use of Diffusion Weighted Imaging in Differentiating Between Maligant and Benign Meningiomas. A Multicenter Analysis.
Surov A; Ginat DT; Sanverdi E; Lim CCT; Hakyemez B; Yogi A; Cabada T; Wienke A
World Neurosurg; 2016 Apr; 88():598-602. PubMed ID: 26529294
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of clinicopathological features in meningiomas: Microscopic brain invasion can predict patient outcome in otherwise benign meningiomas.
Banan R; Abbetmeier-Basse M; Hong B; Dumitru CA; Sahm F; Nakamura M; Krauss JK; Hartmann C
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):724-735. PubMed ID: 33508895
[TBL] [Abstract][Full Text] [Related]
23. New Software for Preoperative Diagnostics of Meningeal Tumor Histologic Types.
Krivoshapkin AL; Sergeev GS; Kalneus LE; Gaytan AS; Murtazin VI; Kurbatov VP; Volkov AM; Kostromskaya DV; Pyatov SM; Amelin ME; Duishobaev AR
World Neurosurg; 2016 Jun; 90():123-132. PubMed ID: 26926798
[TBL] [Abstract][Full Text] [Related]
24. Atypical and malignant canine intracranial meningiomas may have lower apparent diffusion coefficient values than benign tumors.
Fages J; Oura TJ; Sutherland-Smith J; Jennings SH
Vet Radiol Ultrasound; 2020 Jan; 61(1):40-47. PubMed ID: 31600030
[TBL] [Abstract][Full Text] [Related]
25. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
26. A radiopathological classification of dural tail sign of meningiomas.
Qi ST; Liu Y; Pan J; Chotai S; Fang LX
J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
[TBL] [Abstract][Full Text] [Related]
27. Texture analysis of magnetic resonance images to predict histologic grade of meningiomas in dogs.
Banzato T; Bernardini M; Cherubini GB; Zotti A
Am J Vet Res; 2017 Oct; 78(10):1156-1162. PubMed ID: 28945125
[TBL] [Abstract][Full Text] [Related]
28. Deep Learning Model for the Automated Detection and Histopathological Prediction of Meningioma.
Zhang H; Mo J; Jiang H; Li Z; Hu W; Zhang C; Wang Y; Wang X; Liu C; Zhao B; Zhang J; Zhang K
Neuroinformatics; 2021 Jul; 19(3):393-402. PubMed ID: 32974873
[TBL] [Abstract][Full Text] [Related]
29. Can CT and MRI features differentiate benign from malignant meningiomas?
Salah F; Tabbarah A; ALArab Y N; Asmar K; Tamim H; Makki M; Sibahi A; Hourani R
Clin Radiol; 2019 Nov; 74(11):898.e15-898.e23. PubMed ID: 31474303
[TBL] [Abstract][Full Text] [Related]
30. Clinical metric for differentiating intracranial hemangiopericytomas from meningiomas using diffusion weighted MRI.
El-Ali AM; Agarwal V; Thomas A; Hamilton RL; Filippi CG
Clin Imaging; 2019; 54():1-5. PubMed ID: 30469018
[TBL] [Abstract][Full Text] [Related]
31. Ultrarapid Evaluation of Meningioma Malignancy by Intraoperative Flow Cytometry.
Matsuoka G; Eguchi S; Anami H; Ishikawa T; Yamaguchi K; Nitta M; Muragaki Y; Kawamata T
World Neurosurg; 2018 Dec; 120():320-327. PubMed ID: 30144616
[TBL] [Abstract][Full Text] [Related]
32. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
33. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
34. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
35. WHO grade II and III meningiomas: a study of prognostic factors.
Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
[TBL] [Abstract][Full Text] [Related]
36. [Relevance of Simpson's grading system for resections in WHO grade I meningiomas].
Otero A; Tabernero MD; Muñoz MC; Sousa P; Miranda D; Pascual D; Gonçalves JM; Ruiz L
Neurocirugia (Astur); 2017; 28(4):176-182. PubMed ID: 28242156
[TBL] [Abstract][Full Text] [Related]
37. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
38. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for High-Grade Meningioma in Brain and Spine: Systematic Review and Meta-analysis.
Shin HK; Park JH; Cho YH; Kim YH; Hong SH; Kim JH; Roh SW; Jeon SR
World Neurosurg; 2021 Jul; 151():e718-e730. PubMed ID: 33974984
[TBL] [Abstract][Full Text] [Related]
40. Advanced Imaging of Intracranial Meningiomas.
Tamrazi B; Shiroishi MS; Liu CS
Neurosurg Clin N Am; 2016 Apr; 27(2):137-43. PubMed ID: 27012378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
